Business Description
Artgen Biotech PJSC
ISIN : RU000A0JNAB6
Compare
Compare
Traded in other countries / regions
ABIO.Russia IPO Date
2006-05-23Description
Artgen Biotech PJSC formerly Human Stem Cells Institute PJSC is a biotechnology company. It is engaged in the drug discovery, research and development and marketing of proprietary products and services in the field of regenerative medicine, bio-insurance, medical genetics, including reproductive genetics, gene therapy, and biopharmaceutics. The company has developed Neovasculgen, which is a gene therapy drug for the treatment of Peripheral Arterial Disease, including Critical Limb Ischemia and also develops SPRS therapy which entails the use of autologous dermal fibroblasts to repair skin damage due to aging and other structural changes.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.07 | |||||
| 9-Day RSI | 60.97 | |||||
| 14-Day RSI | 53.2 | |||||
| 6-1 Month Momentum % | -11.09 | |||||
| 12-1 Month Momentum % | -19.82 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | 9.8 |
GF Value Rank
| Name | Current | Vs Industry | Vs History |
|---|
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Artgen Biotech PJSC Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₽) | 1,238.131 | ||
| EPS (TTM) (₽) | 0.58 | ||
| Beta | 0 | ||
| Volatility % | 114.42 | ||
| 14-Day RSI | 53.2 | ||
| 14-Day ATR (₽) | 3.940739 | ||
| 20-Day SMA (₽) | 74.83 | ||
| 12-1 Month Momentum % | -19.82 | ||
| 52-Week Range (₽) | 68.04 - 131.64 | ||
| Shares Outstanding (Mil) | 91.58 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Artgen Biotech PJSC Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Artgen Biotech PJSC Stock Events
| Event | Date | Price(₽) | ||
|---|---|---|---|---|
| No Event Data | ||||
Artgen Biotech PJSC Frequently Asked Questions
What is Artgen Biotech PJSC(MIC:ABIO)'s stock price today?
The current price of MIC:ABIO is ₽80.60. The 52 week high of MIC:ABIO is ₽131.64 and 52 week low is ₽68.04.
When is next earnings date of Artgen Biotech PJSC(MIC:ABIO)?
The next earnings date of Artgen Biotech PJSC(MIC:ABIO) is .
Does Artgen Biotech PJSC(MIC:ABIO) pay dividends? If so, how much?
Artgen Biotech PJSC(MIC:ABIO) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers